In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Corcept Therapeutics (CORT – Research Report), with a price target of $76.00. The company’s shares closed ...

We run through the main garden furniture types and accessories, where to buy them from and how to care for them so you don’t need to buy replacements year after year. Plus, we've got tips on how to ...

Ree Drummond’s new furniture collection for The Pioneer Woman is available now at Walmart. Shop couches, coffee tables, bed ...

Inflation trends have been affecting the prices of all kinds of home items, from groceries to furniture. So, what if you need to stock up on furniture with a smaller budget? This might seem ...

Corcept (CORT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Corcept, Amneal, Bioventus, Foghorn and Akebia have ...

Corcept Therapeutics (CORT) shares soared 6.5% in the last trading ... You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Corcept is a member of the Zacks Medical ...

The Apple MacBook Air M2 has been one of the most popular laptops on the market, and it will be hard to top the price you’re seeing here with this Best Buy laptop deal. It has the Apple M2 chip ...

Canaccord Genuity maintained its Buy rating and $78.00 price target for NASDAQ:CORT, Corcept Therapeutics (NASDAQ:CORT). The firm highlighted the company's solid performance as the third quarter ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Kiplinger's annual investing outlook, which includes the best stocks to buy, has been a feature for our readers since 2012. As executive editor for Kiplinger's Personal Finance Magazine ...

In a report released today, Joon Lee from Truist Financial assigned a Buy rating to Corcept Therapeutics (CORT – Research Report). The company’s shares closed yesterday at $40.92. Lee covers ...